Trials / Completed
CompletedNCT00421876
GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,200 (planned)
- Sponsor
- Heart Care Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Cardiac rehabilitation programmes are a proven treatment for individuals with recent myocardial infarction, resulting in reduced morbidity and mortality compared to usual care. Unfortunately, following completion of a cardiac rehabilitation programme, risk factors and lifestyle behaviours may deteriorate. The GOSPEL study investigates the benefits of a programme of continued educational and behavioural intervention to achieve optimal long-term secondary prevention goals.
Detailed description
Study partially sponsored by Società Prodotti Antibiotici
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | multifactorial continued educational - behavioural programme |
Timeline
- Start date
- 2000-12-01
- Completion
- 2005-12-01
- First posted
- 2007-01-15
- Last updated
- 2021-02-03
Locations
74 sites across 2 countries: Italy, Switzerland
Source: ClinicalTrials.gov record NCT00421876. Inclusion in this directory is not an endorsement.